Evidence Evolution by Randox Laboratories Ltd.

The latest addition to the Evidence family of immunoassay analysers, the Evidence Evolution is the world’s first fully automated random access biochip testing platform. The Evidence Evolution is set to revolutionise current diagnostic testing, offering unrivalled quality, efficiency and versatility. Utilising proven and perfected multiplex Biochip Array Technology, the Evidence Evolution is capable of testing for multiple analytes simultaneously from a single sample, providing advanced test consolidation and patient profiling. True onboard random access, state of the art intuitive E-touch software and advanced precision Bio-drive Robotics are but a few of the features the Evidence Evolution can offer. Fully automated, capable of processing 2940 tests per hour, and with an industry leading test menu available, the Evidence Evolution is setting new standards in diagnostic testing. Key Benefits
• The Evidence Evolution processes any required workflow including batch analysis, true random access and instant STAT samples
• Flexible sample system can hold any combination of sample vessels
• Save time and costs: Multiplex testing allows multiple tests to be carried out from a single patient sample
• The world’s first use of Linear Bio-drive Robotics, achieves fast and highly accurate operations with uncompromised quality
• Extensive test menu including routine and novel markers
• State of the art E-Touch software is highly intuitive allowing laboratory technicians to use the system easily with limited training requirements
• Onboard refrigeration of biochips and reagents
• Radio Frequency Identification biochip tracking system allows tracking of reagent usage in order to achieve optimum efficiency